Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Lal Path Labs has submitted copies of newspaper advertisements published in Financial Express and Jansatta on March 19, 2026. The ads serve as a notice to equity shareholders about unclaimed final dividend shares from FY 2018-19 that are due for transfer to the Investor Education and Protection Fund (IEPF) under Section 124(6) of the Companies Act, 2013. Individual notices have also been dispatched by post to affected shareholders at their latest addresses on record. Shareholder details are available on the company's website at www.lalpathlabs.com.
This is a routine regulatory compliance filing with no material impact on the stock or broader shareholder base. Only shareholders who failed to claim their FY 2018-19 final dividend are affected — their shares will be transferred to IEPF if not claimed in time.